Amgen And Direct Relief Partner To Aid Cancer Patients In 18 Developing Countries

Amgen Donates $93 Million Worth of Cancer Medicines THOUSAND OAKS, Calif. and SANTA BARBARA, Calif., Dec. 13, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Direct Relief today announced a joint initiative in which Direct Relief will distribute $93 million worth of Amgen donated cancer treatments and supportive care medicines. This donation will provide cancer patients in 18 developing countries access to Neulasta® (pegfilgrastim), NEUPOGEN® (filgrastim) and Vectibix® (panitumumab). Patients will access the donated medicines through Direct Relief-partner hospitals and clinics in the following countries: Armenia, Cambodia, Dominican Republic, Ethiopia, Ghana, Haiti, Honduras, India, Jama...
Source: Amgen News Release - Category: Pharmaceuticals Tags: Uncategorized Source Type: news